Bionaut Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Series B1

  • Latest Deal Amount
  • $12.9M

  • Investors
  • 29

Bionaut General Information

Description

Developer of microscale robotic devices designed for targeted therapeutic delivery to specific areas affected by severe brain disorders. The company utilizes precision microtechnology to transport biologics or small-molecule therapies directly to localized disease sites, enabling medical professionals to achieve minimally invasive treatments, improve targeting accuracy, and potentially reduce side effects for patients requiring advanced neurological interventions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3767 Overland Avenue
  • Suite 114
  • Los Angeles, CA 90034
  • United States
+1 (425)
Primary Industry
Drug Delivery
Corporate Office
  • 3767 Overland Avenue
  • Suite 114
  • Los Angeles, CA 90034
  • United States
+1 (425)

Bionaut Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bionaut Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B1) 14-May-2024 $12.9M Completed Generating Revenue
4. Later Stage VC (Series B) 22-Nov-2022 Completed Generating Revenue
3. Equity Crowdfunding 10-Jan-2022 Completed Generating Revenue
2. Later Stage VC (Series A) 03-Mar-2021 $20M $23.6M Completed Generating Revenue
1. Seed Round 01-Jan-2019 $3.62M $3.62M Completed Generating Revenue
To view Bionaut’s complete valuation and funding history, request access »

Bionaut Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B1
Series B
Series A
Seed 2 595,237 $0.010000 $0.7 $0.7 1x $0.7 0.82%
Seed 1 5,685,831 $0.010000 $0.56 $0.56 1x $0.56 7.85%
To view Bionaut’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Bionaut Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of microscale robotic devices designed for targeted therapeutic delivery to specific areas affected by severe
Drug Delivery
Los Angeles, CA
19 As of 2026

Carlsbad, CA

Vienna, Austria
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bionaut Competitors (18)

One of Bionaut’s 18 competitors is Renova Therapeutics, a Venture Capital-Backed company based in Carlsbad, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Renova Therapeutics Venture Capital-Backed Carlsbad, CA
Pfizer (Vienna) Corporation Vienna, Austria
Neurona Therapeutics Formerly VC-backed South San Francisco, CA
Egenesis Venture Capital-Backed Cambridge, MA
Arbor Biotechnologies Venture Capital-Backed Cambridge, MA
You’re viewing 5 of 18 competitors. Get the full list »

Bionaut Patents

Bionaut Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260191552-A1 Dynamic medical tool for tissue penetration Pending 06-Jan-2025
US-20260060596-A1 Systems and methods for intracranial neural monitoring and modulation via wireless means Pending 05-Sep-2024
US-20260020846-A1 Miniature biopsy device Pending 22-Jul-2024
US-20250312568-A1 Catheter assembly with miniature device Pending 09-Apr-2024
US-20250072988-A1 Miniature device and system for remotely controlling it within a patient Pending 03-Aug-2023 A61B34/73
To view Bionaut’s complete patent history, request access »

Bionaut Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bionaut Investors (29)

Investor Name Investor Type Holding Investor Since Participating Rounds
Altitude Life Science Ventures Venture Capital Minority
Alumni Ventures Venture Capital Minority
BakerBridge Capital Venture Capital Minority
Frühstarter Ventures Angel Group Minority
Mayo Clinic Corporation Minority
You’re viewing 5 of 29 investors. Get the full list »

Bionaut FAQs

  • When was Bionaut founded?

    Bionaut was founded in 2016.

  • Where is Bionaut headquartered?

    Bionaut is headquartered in Los Angeles, CA.

  • What is the size of Bionaut?

    Bionaut has 19 total employees.

  • What industry is Bionaut in?

    Bionaut’s primary industry is Drug Delivery.

  • Is Bionaut a private or public company?

    Bionaut is a Private company.

  • What is the current valuation of Bionaut?

    The current valuation of Bionaut is .

  • What is Bionaut’s current revenue?

    The current revenue for Bionaut is .

  • How much funding has Bionaut raised over time?

    Bionaut has raised $83M.

  • Who are Bionaut’s investors?

    Altitude Life Science Ventures, Alumni Ventures, BakerBridge Capital, Frühstarter Ventures, and Mayo Clinic are 5 of 29 investors who have invested in Bionaut.

  • Who are Bionaut’s competitors?

    Renova Therapeutics, Pfizer (Vienna), Neurona Therapeutics, Egenesis, and Arbor Biotechnologies are some of the 18 competitors of Bionaut.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process